Market Overview:
The global sheep and goat pox vaccines market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for sheep and goat meat, rising awareness about animal health, and growing investments by key players in research and development (R&D) activities. Based on type, the global sheep and goat pox vaccines market can be segmented into live vaccines and killed vaccines. The live vaccine segment is expected to account for a larger share of the global market than the killed vaccine segment during the forecast period. This can be attributed to factors such as ease of administration, lower cost, better efficacy rates, and longer shelf life as compared with killed vaccines. Based on application, the global sheep and goat pox vaccines market can be divided into two segments: sheep vaccinationandgoat vaccination .
Product Definition:
Sheep and Goat Pox Vaccines are used to prevent the disease in sheep and goats.
Live Vaccines:
Live vaccines are used to develop immunity against diseases in animals. These vaccines stimulate the animal's immune system to fight off future infections. Live attenuated vaccine is a type of vaccine, which is made by removing some of the harmful parts (e.g., genes) from an active virus and replacing them with harmless genes so that when given to an animal, it stimulates its own immune system to produce antibodies without causing disease in itself.
Killed Vaccines:
Killed vaccines are those used to immunize animals against a disease, but cannot transmit the infection to humans. The most common type of vaccine is formalin-fixed tissue or cell culture. These products have been used for decades and are considered safe and effective in preventing diseases in animals as well as people.
Application Insights:
The demand for the sheeppox vaccine is expected to be high in countries where goat farming is practiced on a large scale, such as India and China. In addition, favorable government regulations that support the development of industries related to animal health are anticipated to boost industry growth over the forecast period.
¢â‚¬Å“India has one of the largest flock of goats which contributes significantly towards its meat and dairy products consumption globally. This factor along with favorable government policies promoting investments in livestock-related activities will drive industry expansion over the next eight years. ¢â‚¬Å“China has been identified as one of the major markets for vaccines due to rapid industrialization coupled with increasing urbanization since 1990s when commercial production was started there.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of ruminant livestock is one of the major factors contributing to this dominance. Furthermore, high awareness levels pertaining to animal health and diseases are also expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to be the fastest-growing region during the forecast period owing to increasing demand for meat products coupled with rising disposable income and improved healthcare infrastructure in emerging economies such as China, India, Indonesia, Malaysia and Thailand. Moreover, several international companies are investing heavily in this sector due to high potential for revenue generation from these markets at relatively lower costs than developed regions. These aforementioned factors will serve Asia Pacific as a robust platform for future growth across all other regions listed above it during the same period (2018 - 2030).
Growth Factors:
- Increasing demand for sheep and goat meat across the globe is expected to drive the growth of sheep and goat pox vaccines market over the forecast period.
- Growing awareness about animal health and increasing investments by government bodies for livestock development are some of the other factors anticipated to fuel the growth of this market in near future.
- Rising demand for milk, wool, and hides from sheep population is another key factor estimated to propel the growth of this market in coming years.
- Technological advancements in vaccine production are projected to create new opportunities for players operating in this market during forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Sheep and Goat Pox Vaccines Market Research Report
By Type
Live Vaccines, Killed Vaccines
By Application
Sheep, Goat
By Companies
Agrovet, Biopharma, Dollvet, FGBI - Federal Centre for Animal Health, Hester Biosciences Limited, Indian Immunologicals Limited, Institut Pasteur d'Algerie, Intervac (PVT) Ltd., JOVAC, Tiankang Biopharmacuetical, Vetal Company, Veterinary Research Institute
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Sheep and Goat Pox Vaccines Market Report Segments:
The global Sheep and Goat Pox Vaccines market is segmented on the basis of:
Types
Live Vaccines, Killed Vaccines
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Sheep, Goat
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Agrovet
- Biopharma
- Dollvet
- FGBI - Federal Centre for Animal Health
- Hester Biosciences Limited
- Indian Immunologicals Limited
- Institut Pasteur d'Algerie
- Intervac (PVT) Ltd.
- JOVAC
- Tiankang Biopharmacuetical
- Vetal Company
- Veterinary Research Institute
Highlights of The Sheep and Goat Pox Vaccines Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Live Vaccines
- Killed Vaccines
- By Application:
- Sheep
- Goat
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Sheep and Goat Pox Vaccines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Sheep and goatpox vaccines are used to prevent the spread of sheep and goatpox, respectively.
Some of the key players operating in the sheep and goat pox vaccines market are Agrovet, Biopharma, Dollvet, FGBI - Federal Centre for Animal Health, Hester Biosciences Limited, Indian Immunologicals Limited, Institut Pasteur d'Algerie, Intervac (PVT) Ltd., JOVAC, Tiankang Biopharmacuetical, Vetal Company, Veterinary Research Institute.
The sheep and goat pox vaccines market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Sheep and Goat Pox Vaccines Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Sheep and Goat Pox Vaccines Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Sheep and Goat Pox Vaccines Market - Supply Chain
4.5. Global Sheep and Goat Pox Vaccines Market Forecast
4.5.1. Sheep and Goat Pox Vaccines Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Sheep and Goat Pox Vaccines Market Size (000 Units) and Y-o-Y Growth
4.5.3. Sheep and Goat Pox Vaccines Market Absolute $ Opportunity
5. Global Sheep and Goat Pox Vaccines Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Sheep and Goat Pox Vaccines Market Size and Volume Forecast by Type
5.3.1. Live Vaccines
5.3.2. Killed Vaccines
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Sheep and Goat Pox Vaccines Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Sheep and Goat Pox Vaccines Market Size and Volume Forecast by Application
6.3.1. Sheep
6.3.2. Goat
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Sheep and Goat Pox Vaccines Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Sheep and Goat Pox Vaccines Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Sheep and Goat Pox Vaccines Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Sheep and Goat Pox Vaccines Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Sheep and Goat Pox Vaccines Demand Share Forecast, 2019-2026
9. North America Sheep and Goat Pox Vaccines Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Sheep and Goat Pox Vaccines Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Sheep and Goat Pox Vaccines Market Size and Volume Forecast by Application
9.4.1. Sheep
9.4.2. Goat
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Sheep and Goat Pox Vaccines Market Size and Volume Forecast by Type
9.7.1. Live Vaccines
9.7.2. Killed Vaccines
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Sheep and Goat Pox Vaccines Demand Share Forecast, 2019-2026
10. Latin America Sheep and Goat Pox Vaccines Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Sheep and Goat Pox Vaccines Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Sheep and Goat Pox Vaccines Market Size and Volume Forecast by Application
10.4.1. Sheep
10.4.2. Goat
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Sheep and Goat Pox Vaccines Market Size and Volume Forecast by Type
10.7.1. Live Vaccines
10.7.2. Killed Vaccines
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Sheep and Goat Pox Vaccines Demand Share Forecast, 2019-2026
11. Europe Sheep and Goat Pox Vaccines Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Sheep and Goat Pox Vaccines Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Sheep and Goat Pox Vaccines Market Size and Volume Forecast by Application
11.4.1. Sheep
11.4.2. Goat
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Sheep and Goat Pox Vaccines Market Size and Volume Forecast by Type
11.7.1. Live Vaccines
11.7.2. Killed Vaccines
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potntial Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Sheep and Goat Pox Vaccines Demand Share, 2019-2026
12. Asia Pacific Sheep and Goat Pox Vaccines Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Sheep and Goat Pox Vaccines Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Sheep and Goat Pox Vaccines Market Size and Volume Forecast by Application
12.4.1. Sheep
12.4.2. Goat
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Sheep and Goat Pox Vaccines Market Size and Volume Forecast by Type
12.7.1. Live Vaccines
12.7.2. Killed Vaccines
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Sheep and Goat Pox Vaccines Demand Share, 2019-2026
13. Middle East & Africa Sheep and Goat Pox Vaccines Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Sheep and Goat Pox Vaccines Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Sheep and Goat Pox Vaccines Market Size and Volume Forecast by Application
13.4.1. Sheep
13.4.2. Goat
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Sheep and Goat Pox Vaccines Market Size and Volume Forecast by Type
13.7.1. Live Vaccines
13.7.2. Killed Vaccines
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Sheep and Goat Pox Vaccines Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Sheep and Goat Pox Vaccines Market: Market Share Analysis
14.2. Sheep and Goat Pox Vaccines Distributors and Customers
14.3. Sheep and Goat Pox Vaccines Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Agrovet
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Biopharma
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Dollvet
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. FGBI - Federal Centre for Animal Health
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Hester Biosciences Limited
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Indian Immunologicals Limited
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Institut Pasteur d'Algerie
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Intervac (PVT) Ltd.
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. JOVAC
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Tiankang Biopharmacuetical
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Vetal Company
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Veterinary Research Institute
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
